Skip directly to searchSkip directly to the site navigationSkip directly to the page's main content

More Information and References for Deaths due to Unintentional Poisoning

References and Community Resources

1. WISQARS, 2020 fatal and non-fatal injury data: [] 2. CDC WONDER, 2000 and 2020 unintentional poisoning mortality: [] Additional information: *CDC National Center for Environmental Health: [ Carbon Monoxide Poisoning] *CDC National Center for Injury Prevention and Control: [ Drug Overdose] *CDC National Center for Injury Prevention and Control [ Overdose Data to Action (OD2A)] *[ NJ Overdose Data Dashboard] *[ NJCARES Opioid-Related Data and Information] *[ NJ Operation Helping Hand] *[ NJ Governor's Council on Alcoholism and Drug Abuse] *[ NJDOH Naloxone (Narcan) Program] *[ NJDOH Five Minutes to Help] *[ NJDHS SUD Waiver Program] allows federal matching funds to be used for expanding substance use disorder treatment services *[ NJDOH Standing Order Program - Naloxone] *[ NJDOL Pathways to Recovery] program *[ NJOAG/Division of Consumer Affairs Project Medicine Drop] In 2022, the Governor announced that New Jersey is set to receive $641 million from settlements with an opioid manufacturer and the country's 3 largest pharmaceutical distributors. Paid through 2038, the funds will support state and local programs focused on treatment, prevention, and other strategies to address the opioid issue in New Jersey. [] *[ NJ Patient Safety Act (P.L. 2004, c. 9)] *[ NJ Overdose Prevention Act (P.L. 2013, c. 46)] *[ NJ Substance Abuse Disorder Law (P.L. 2017, c. 28)] *[ NJ Senate Bill No. 2323 (P.L. 2021, c.54)] : Prescribers required to co-prescribe naloxone or another opioid antidote for patients receiving high doses of opioids or certain drug combinations *[ NJ Senate Bill No. 3491 (P.L. 2021, c.152)]: Allow paramedics to carry and administer buprenorphine to treat acute opioid withdrawal symptoms after naloxone reversal *[ NJ Assembly Bill No. 5703 (P.L. 2021, c.157)]: Waiver of prior authorization requirements for medication-assisted treatment (MAT) *[ NJ Sente Bill No. 3009 (P.L. 2021, c.396)]: Expansion of Harm Reduction services to provide sterile syringes and additional support services to persons who use drugs intravenously *[ NJ Assembly Bill No. 798 (P.L. 2021, c.430)]: Establishes County and Local Overdose Fatality Review Teams (OFRTs)

The information provided above is from the Department of Health's NJSHAD web site ( The information published on this website may be reproduced without permission. Please use the following citation: " Retrieved Thu, 23 May 2024 1:24:56 from Department of Health, New Jersey State Health Assessment Data Web site: ".

Content updated: no date